Can a shot into the tumor boost immunity before surgery?
NCT ID NCT02812524
First seen Apr 25, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This early-stage study looks at whether injecting the drug ipilimumab directly into head and neck tumors before surgery is safe and practical. About 18 adults with squamous cell carcinoma of the head and neck will receive the injection, then have their tumor removed as planned. Researchers will check if the injection delays surgery and how it affects the immune system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Portland Providence Medical Center
Portland, Oregon, 97213, United States
Conditions
Explore the condition pages connected to this study.